Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

171
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
171
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

103
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103
Censoring Survival Data01:09

Censoring Survival Data

68
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
68
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

99
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust Cancer Biomarker Identification From Matched Transcriptomic Data Via Bootstrapped Regularized Conditional Logistic Regression.

Cancer informatics·2025
Same author

Pseudo datasets estimate feature attribution in artificial neural networks.

Scientific reports·2025
Same author

Cancer classification and functional pathway discovery using TCGA transcriptomic profiles: A matched case-control framework.

Journal of bioinformatics and computational biology·2025
Same author

Optimism and mental health in college students: the mediating role of sleep quality and stress.

Frontiers in psychology·2024
Same author

Conditional score approaches to errors-in-variables competing risks data in discrete time.

Statistics in medicine·2024
Same author

Overlapping group screening for binary cancer classification with TCGA high-dimensional genomic data.

Journal of bioinformatics and computational biology·2023
Same journal

Widening Health Inequality and Causal Metabolic Drivers in Global Colorectal Cancer: A Multi-Dimensional Study.

Cancer informatics·2026
Same journal

GFAP-Dependent Transcriptional Dynamics and Cellular Heterogeneity in Primary, Recurrent, and Grade III Gliomas.

Cancer informatics·2026
Same journal

Translating Data Into Clinical Tools: An Integrative Strategy for Precision Biomarker Identification in Soft Tissue Sarcoma Diagnosis and Prognosis.

Cancer informatics·2026
Same journal

The MAPK Pathway Coordinates an Immunosuppressive Microenvironment in Colorectal Cancer: A Single-Cell Guided Prognostic Model.

Cancer informatics·2026
Same journal

Multi-Scale Cross-Attention Multiple Instance Learning Network for Automated Classification of Colorectal Polyps.

Cancer informatics·2026
Same journal

LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies.

Cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Multicategory Survival Outcomes Classification via Overlapping Group Screening Process Based on Multinomial Logistic

Jie-Huei Wang1, Po-Lin Hou1, Yi-Hau Chen2

  • 1Department of Mathematics, National Chung Cheng University, Chiayi City, Taiwan.

Cancer Informatics
|October 10, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a new computational method to accurately classify cancer patient survival outcomes using transcriptomic data. The approach effectively identifies key genes and gene interactions, improving multi-category cancer diagnosis.

Keywords:
Multicategory classificationTCGAmultinomial logistic regressionoverlapping group screeningprecision medicine

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: Jun 11, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Genomics

Background:

  • Classifying multicategory survival outcomes in cancer patients is crucial for identifying specific biomarkers.
  • Transcriptomic data analysis faces challenges like high dimensionality, feature contamination, and data imbalance, leading to unstable diagnostic models.
  • Extending binary classification methods to multi-class problems with high-dimensional transcriptomic data remains complex.

Purpose of the Study:

  • To develop an accurate microarray-based multicategory cancer diagnosis model using transcriptomic data.
  • To identify important genes and gene-gene interactions associated with multicategory survival outcomes.
  • To address challenges in multi-class classification of high-dimensional biological data.

Main Methods:

  • Employed a One-versus-One strategy to convert multi-class classification into multiple binary classifications.
  • Utilized overlapping group screening with binary logistic regression to incorporate pathway information.
  • Applied random oversampling to manage class imbalance in real-world cancer datasets.

Main Results:

  • The proposed method demonstrated enhanced cancer diagnosis accuracy compared to approaches ignoring pathway information.
  • Evaluations on simulated and real transcriptomic data (kidney renal papillary cell carcinoma, lung adenocarcinoma, head and neck squamous cell carcinoma) confirmed the method's effectiveness.
  • Identified cancer-related gene-gene interaction biomarkers and their network structures.

Conclusions:

  • The proposed method effectively enhances cancer diagnosis by accurately predicting patient probabilities across survival outcome classes.
  • Identified gene-gene interactions serve as valuable biomarkers for multicategory survival outcome prediction.
  • The study provides a robust framework for analyzing high-dimensional transcriptomic data in cancer research.